Tag Archives: beating

High street pharmacy offers cervical cancer vaccine for £405

vaccination2

High street pharmacy offers cervical cancer vaccine for £405

The Cervarix vaccine which protects against the two strains of humanpapilloma virus responsible for the majority of cases of cervical cancer is available to girls aged between 12 and 18 on the NHS as part of a national vaccination programme.

However older women have been requesting the vaccine from their GPs only to be turned down in most cases. Cervarix and its rival Gardasil are available privately.

Government scientists advised that young girls be offered the vaccine as the virus is transmitted through intimate contact and sex and is less effective in women who have already been exposed to the virus.

Fears have also been raised that women may be given a false sense of security through having had the vaccine and not attend for cervical smear tests in future.

Boots the chemist is offering the service to women aged between 18 and 54 in 134 of its stores in England and Wales following successful pilots in ten stores in London which began in November last year.

Lloydspharmacy also offers the vaccine in almost 300 of its stores.

Women will not be tested to establish if they have already been infected with the HPV strains 16 and 18 which are included in the vaccine and so cannot be sure whether it will offer them substantial benefit.

Evidence considered by the Government advisers on the Joint Committee on Vaccination and Immunisation showed that one in ten women aged between 20 and 29 were already infected with HPV strain 16.

In recommending that girls aged 12 be routinely vaccinated with a catchup campaign offering it to all girls aged up to 18, a statement from the JCVI said: “Vaccination of girls above this age was not cost-effective given the assumed cost of vaccine and administration, and the increase in prevalence of previous infection in this age group.”

Sarah Woolnough, Cancer Research UK’s head of policy, said: “The best way that older women can protect themselves against cervical cancer is through the free NHS cervical screening programme, which has saved 100,000 lives since its introduction in 1988.

“We strongly advise all women to attend cervical screening when invited, even if they have had the HPV vaccination.

“We don’t yet know how effective the vaccine is in women who have already come into contact with HPV.”

However Dr Anne Szarewski, clinical consultant at Cancer Research UK’s centre for epidemiology at the Wolfson Institute of Preventive Medicine, is backing the Boots programme.

She said the chances of having contracted both strain 16 and 18 were just five per cent.

Dr Szarewski said: “And, even if you do catch HPV then a lot of people – around 50 per cent – will clear it from their bodies and not be immune.

“Even if you have an antibody response, this does not mean you are protected in the future.

“There is no reason why an individual woman should not have this vaccine.”

Dr Graham Marshall, Boots Medical Director, said: “As this vaccination is only available on the NHS through the schools’ vaccination programme, most women above the age of 18 will not be aware that they could benefit from the vaccination. Pharmacists are well placed to offer this service with convenient high street locations and a welcoming, familiar atmosphere.

“Boots pharmacists have undergone comprehensive training – written and agreed by an independent panel of experts – to provide this innovative, patient-led service. The consultation includes advice on sexual health and the importance of regular cervical screening.”

A Department of Health spokesman said: “The NHS runs a free HPV vaccination programme for girls from 12-18 years of age which will save the lives of up to 400 women each year.

“We strongly encourage all women over 25 to be regularly screened to help protect them from cervical cancer.

“Careful consideration was given to vaccinating older women. However, the national HPV vaccine programme aims to protect girls and young women before they are exposed to the human papillomavirus, where research shows that vaccination is most effective. The programme has been a great success with over three quarters of girls aged 12-13 years already having received all three doses of the vaccine.”

High street pharmacy, High street pharmacy Health, High street pharmacy Health Latest, High street pharmacy Health Information, High street pharmacy Health information, High street pharmacyHealth Photo,Exercising for Weight Health photo, High street pharmacy Health Latest, High street pharmacyHealth latest, Exercising for Weight  Health Story, Healthy Minnesota  Health story, High street pharmacy Video, High street pharmacy video, High street pharmacy Health History, High street pharmacy Health history, High street pharmacyover Picture, history, High street pharmacy Asia,  Healthy Minnesota  asia, High street pharmacy Gallery, Exercising for Weight  gallery, High street pharmacy Photo Gallery, Healthy Minnesota  photo gallery, High street pharmacy Picture, High street pharmacy picture, High street pharmacy Web, Malaysia Health, web Health, web Health picture, video photo, video surgery, gallery, laparoscopy, virus, flu, drug, video, Health Health, calories, photo, nutrition, health video, symptoms, cancer, medical, beating, diet, physical, Training, organic, gym, blister, exercise, weightloss, surgery, spiritual, eating, tips, skin, operation, bf1, High, street, pharmacy, offers, cervical, cancer, vaccine, for, £405

Pneumonia bugs kill 1.2 million children: study

THE DEVIL WEARS PRADA

Pneumonia bugs kill 1.2 million children: study

More than a million children die every year from two pneumonia-causing diseases easily prevented with vaccines, researchers reported on Thursday.

Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib, they found.

Their study, published in the Lancet medical journal, found an estimated 14.5 million cases of pneumococcal disease such as pneumonia and meningitis worldwide, most caused by S. pneumoniae, with 826,000 deaths among children under 5.

Safe and effective vaccines exist for both, but use of Hib vaccine has only recently expanded to low-income countries and pneumococcal vaccine is not included in national immunization programs in the developing world yet, the researchers said.

“Our findings underscore the urgent need for prevention efforts throughout the developing world,” said Kate O’Brien, of Johns Hopkins University in Baltimore, who led the study.

“The need for vaccination and improved treatment is particularly urgent in Africa and Asia, which together account for 95 percent of all pneumococcal deaths.”

Another study by the United Nation’s children’s fund UNICEF showed that better prevention methods for malaria and action to reduce mother-to-child AIDS virus transmission had reduced childhood deaths from other causes.

It found 8.8 million children under five died in 2008 compared with 12.5 million in 1990. But 99 percent of the children who died lived in poor countries.

Wyeth’s Prevnar, which protects against seven strains of S. pneumonia, is part of the routine childhood vaccination package in the United States and other developed countries.

Several companies including Merck and Co. and GlaxoSmithKline make Hib vaccines. They prevent meningitis caused by H. influenzae, pneumonia and a severe throat infection called epiglottitis.

The non-profit Global Alliance for Vaccines and Immunization or GAVI provides Hib vaccine to 35 African nations.

Pneumonia bugs kill, Pneumonia bugs kill Health, Pneumonia bugs kill Health Latest, Pneumonia bugs kill Health Information, Pneumonia bugs kill Health information, Pneumonia bugs killHealth Photo,Exercising for Weight Health photo, Pneumonia bugs kill Health Latest, Pneumonia bugs killHealth latest, Exercising for Weight  Health Story, Healthy Minnesota  Health story, Pneumonia bugs kill Video, Pneumonia bugs kill video, Pneumonia bugs kill Health History, Pneumonia bugs kill Health history, Pneumonia bugs killover Picture, history, Pneumonia bugs kill Asia,  Healthy Minnesota  asia, Pneumonia bugs kill Gallery, Exercising for Weight  gallery, Pneumonia bugs kill Photo Gallery, Healthy Minnesota  photo gallery, Pneumonia bugs kill Picture, Pneumonia bugs kill picture, Pneumonia bugs kill Web, Malaysia Health, web Health, web Health picture, video photo, video surgery, gallery, laparoscopy, virus, flu, drug, video, Health Health, calories, photo, nutrition, health video, symptoms, cancer, medical, beating, diet, physical, Training, organic, gym, blister, exercise, weightloss, surgery, spiritual, eating, tips, skin, operation, bf1, Pneumonia, bugs, kill, 1.2, million, children, study

Studies show one dose of H1N1 vaccine may be enough

in.reuters.com

Studies show one dose of H1N1 vaccine may be enough

Two studies published on Thursday confirmed that a single dose of swine flu vaccine can protect people from the new pandemic H1N1 virus — welcome news to global health officials who had worried that people might need two doses.

Australian vaccine maker CSL Inc. released new data showing its vaccine got what would be considered a protective immune response with a singe dose, and Swiss drug maker Novartis presented a study confirming a report from last week showing its vaccine worked at an even lower dose when boosted with an immune system compound called an adjuvant.

Both studies, published in the New England Journal of Medicine, may lay to rest fears about the logistical nightmare of trying to vaccinate hundreds of millions of people globally with two doses of H1N1 vaccine — given a month apart — in addition to a single recommended dose of seasonal influenza vaccine.

Last week China’s Sinovac also reported its vaccine protected patients with a single dose.

The new H1N1 strain of flu, declared a pandemic in June, could eventually infect one third of the world’s population, or 2 billion people, according to the World Health Organization.

Because it is a new strain, infectious disease experts had said people would likely need two doses to get full immunity against the virus. They are rushing to put in place vaccine programs as the weather cools in the Northern Hemisphere and the traditional flu season starts.

About 20 pharmaceutical companies including Sanofi-Aventis, GlaxoSmithKline and AstraZeneca’s MedImmune unit are also racing to develop H1N1 vaccine as governments scramble to secure supplies.

The United States hopes to vaccinate 160 million Americans by the beginning of December.

NASAL SPRAY READY

Also on Thursday, MedImmune said its inhaled vaccine against the pandemic H1N1 virus could be ready to start shipping to the U.S. government by the end of September.

MedImmune’s Dr. Raburn Mallory said the company has submitted safety data for its nasal spray swine flu vaccine to the U.S. Food and Drug Administration.

“There are no red flags there. We think we can have 5 million doses ready to distribute at the end of September,” Mallory said in an interview. U.S. officials had not expected vaccination to begin until mid-October.

The company has 5 million doses in spray devices now, a company spokeswoman said, adding that a more conservative estimate would be that 3.5 million doses could be sent out by the end of September.

U.S. health officials said they started testing swine flu vaccines in pregnant women this week and were scheduled on Friday to report on results of some of the tests being done on various swine flu vaccines for the U.S. market.

The U.S. Food and Drug Administration is licensing H1N1 vaccines as if they are a simple reformulation of the seasonal flu vaccine. This does not require clinical tests, but the National Institutes of Health is running clinical tests anyway, to be sure it is safe and to find the best dose.

Governments in Europe have started to take delivery of H1N1 swine flu vaccines but are awaiting a license from European authorities before they can start mass vaccinations.

“The immune response to all these vaccines is a very high response, whatever type of vaccine it is, whether it is adjuvanted or non-adjuvanted,” Thomas Lonngren, executive director of the European Medicines Agency or EMEA, told a news briefing.

Studies show , Studies show  Health, Studies show  Health Latest, Studies show  Health Information, Studies show  Health information, Studies show Health Photo,Exercising for Weight Health photo, Studies show  Health Latest, Studies show Health latest, Exercising for Weight  Health Story, Healthy Minnesota  Health story, Studies show  Video, Studies show  video, Studies show  Health History, Studies show  Health history, Studies show over Picture, history, Studies show  Asia,  Healthy Minnesota  asia, Studies show  Gallery, Exercising for Weight  gallery, Studies show  Photo Gallery, Healthy Minnesota  photo gallery, Studies show  Picture, Studies show  picture, Studies show  Web, Malaysia Health, web Health, web Health picture, video photo, video surgery, gallery, laparoscopy, virus, flu, drug, video, Health Health, calories, photo, nutrition, health video, symptoms, cancer, medical, beating, diet, physical, Training, organic, gym, blister, exercise, weightloss, surgery, spiritual, eating, tips, skin, operation, bf1, Studies, show, one, dose, of, H1N1, vaccine, may, be, enough